Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Tuesday Feb 06, 2024
touchMDT – Patient-centric care for prurigo nodularis – Discussion 3
Tuesday Feb 06, 2024
Tuesday Feb 06, 2024
touchMDT for touchIMMUNOLOGY
Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
- Patient advocate: Ms Sailaja Maganti, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/
Tuesday Feb 06, 2024
touchMDT – Management of prurigo nodularis – Discussion 2
Tuesday Feb 06, 2024
Tuesday Feb 06, 2024
touchMDT for touchIMMUNOLOGY
Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/
Tuesday Feb 06, 2024
touchMDT – Burden of prurigo nodularis – Discussion 1
Tuesday Feb 06, 2024
Tuesday Feb 06, 2024
touchMDT for touchIMMUNOLOGY
Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
- Patient advocate: Ms Sailaja Maganti, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/
Tuesday Feb 06, 2024
touchMDT – Patient-centric care for prurigo nodularis – Discussion 3
Tuesday Feb 06, 2024
Tuesday Feb 06, 2024
touchMDT for touchDERMATOLOGY
Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
- Patient advocate: Ms Sailaja Maganti, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//
Tuesday Feb 06, 2024
touchMDT – Management of prurigo nodularis – Discussion 2
Tuesday Feb 06, 2024
Tuesday Feb 06, 2024
touchMDT for touchDERMATOLOGY
Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//
Tuesday Feb 06, 2024
touchMDT – Burden of prurigo nodularis – Discussion 1
Tuesday Feb 06, 2024
Tuesday Feb 06, 2024
touchMDT for touchDERMATOLOGY
Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
- Patient advocate: Ms Sailaja Maganti, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//
Wednesday Jan 24, 2024
Is HER2 targeting on the horizon for urothelial carcinoma?
Wednesday Jan 24, 2024
Wednesday Jan 24, 2024
touchFOCUS for touchONCOLOGY
A genitourinary medical oncologist considers the potential for targeting HER2 in the treatment of urothelial carcinoma, including the rationale for HER2 as a target, approaches to HER2 testing, the latest data on emerging HER2-targeted therapies and the potential implications for future clinical practice.
The expert:
- Dr Vadim Koshkin - University of California San Francisco, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
Wednesday Jan 24, 2024
Wednesday Jan 24, 2024
touchIN CONVERSATION for touchIMMUNOLOGY
Listen to Dr Shounak Majumder (Mayo Clinic, Rochester, MN, USA) in conversation with Professor Matthias Löhr (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden) on how to optimize the diagnosis and management of patients with IgG4-related gastrointestinal (GI) disease.
They respond to questions from the gastroenterology, hepatology and rheumatology clinical communities on:
- Challenges of diagnosing IgG4-related GI disease
- Differentiating type 1 autoimmune pancreatitis from type 2
- Therapeutic strategies for IgG4-related GI disease
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchimmunology.com
Wednesday Jan 10, 2024
Wednesday Jan 10, 2024
touchIN CONVERSATION for touchONCOLOGY
Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma.
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
Wednesday Jan 10, 2024
Wednesday Jan 10, 2024
touchIN CONVERSATION for touchHAEMATOLOGY
Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma.
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchhaematology.com